Royal DSM offers to buy Kensey Nash for about $350 million in cash
Deal is expected to expand DSM's footprint in the regenerative medicine business
Offer comes as DSM is revamping to become life sciences and materials business
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash (press release)
Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM (DSM) (NYSE Euronext: DSM KON), under which DSM has agreed to acquire all of the common stock of Kensey Nash through a cash tender offer, ...
